Mode
Text Size
Log in / Sign up
N/A N=55 Randomized Single-blind Treatment

Improving Negative Symptoms of Psychosis In Real-world Environments

Schizophrenia

Enrolled (actual)
55
Serious AEs
0.0%
Results posted
Nov 2020
Primary outcome: Primary: Clinical Assessment Interview for Negative Symptoms (CAINS) — .0667; -.0588 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
CBSST-CCT (Behavioral); Goal focused supportive contact (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, San Diego
Primary completion
Sep 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Clinical Assessment Interview for Negative Symptoms (CAINS)
.0667; -.0588
SECONDARY
MATRICS Consensus Cognitive Battery (MCCB)
.8778; -.0065
SECONDARY
UCSD Performance-based Skills Assessment-Brief (UPSA-B)
3.1667; 1.3882
SECONDARY
Social Skills Performance Assessment (SSPA)
.1824; .0548
SECONDARY
Specific Levels of Functioning Scale (SLOF)
.1718; .2498
SECONDARY
Independent Living Skills Survey (ILSS)
.0121; -.0078
SECONDARY
Defeatist Performance Attitudes Scale (DPAS)
-3.8667; 1.1765
SECONDARY
Scale for the Assessment of Negative Symptoms (SANS)
-.8000; -.1176

Summary

This study will compare Cognitive Behavioral Social Skills Training-Compensatory Cognitive Training (CBSST-CCT) to a goal-focused supportive contact group to see which intervention better improves symptoms and functioning in people with schizophrenia.

Eligibility Criteria

Inclusion Criteria

MUST BE A RESIDENT OF BROADWAY HOME, SAN DIEGO, OR A SERVICE USER OF THE MEETING PLACE, ARETA CROWELL, OR PROJECT ENABLE.

  • Voluntary informed consent to participate
  • Age 18 to 65
  • DSM-IV diagnosis of schizophrenia or schizoaffective disorder based on MINI/SCID
  • Moderate-to-severe negative symptoms on the Clinical Assessment Interview for Negative Symptoms (CAINS total score >19)
  • ≥ 6th grade reading level on the Wide Range Achievement Test-4 Reading subtest (needed for reading treatment manual)
  • Stable on medications; no changes within 3 months prior to enrollment

Exclusion Criteria

  • Prior CBT, SST, or CCT in the past 5 years
  • Severe positive symptoms on the Positive and Negative Syndrome Scale (PANSS Delusions, Disorganization, Hallucinations, or Suspiciousness >5)
  • Severe depression on the Calgary Depression Scale for Schizophrenia (CDSS >8)
  • Ocular damage/disease/surgery/medications that affect pupil dilation
  • DSM-IV alcohol or substance dependence diagnosis in past 6 months based on the MINI or SCID
  • Level of care required interferes with outpatient therapy (e.g., hospitalized; severe medical illness) .
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02170051). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search